Literature DB >> 3791063

Primary degenerative dementia without Alzheimer pathology.

A W Clark, C L White, H J Manz, I M Parhad, B Curry, P J Whitehouse, J Lehmann, J T Coyle.   

Abstract

To define the pathology in cases of non-Alzheimer primary degenerative dementia (non-AD PDD), we have studied autopsies from four medical centres accessioned in consecutive years since 1976. Neurochemical studies of the basal forebrain-cortical (BF-C) cholinergic system have been conducted in cases from which frozen tissue was available. Twenty-two cases (mean age 70 years, range 47-86) in which the history was consistent with PDD, but which did not meet anatomic criteria for AD, were selected. Approximately 70 cases of PDD, which were accessioned in the same years and met the anatomic criteria for AD, were excluded. The pathologic findings permitted a classification into six groups: Lewy body disease (LBD), 4 cases; Pick's disease, 6 cases: cortical degeneration with motor neuron disease (CDmnd), 2 cases; hippocampal and temporal lobe sclerosis, 3 cases; few or nonspecific abnormalities, 5 cases; other disorders, 2 cases. Our findings suggest that LBD and Pick's disease account for a large proportion of cases of non-AD PDD in the presenile age group, but that a large number of other disorders occasionally present as PDD. Careful examination of the motor systems, as well as cerebral structures relate to cognitive function, is important in the neuropathologic evaluation. Lesions of the BF-C cholinergic system have been most consistent and severe in LBD, and have not been identified in CDmnd.

Entities:  

Mesh:

Year:  1986        PMID: 3791063     DOI: 10.1017/s0317167100037136

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  17 in total

Review 1.  The birth and early evolution of the frontotemporal dementia (FTD) concept.

Authors:  Arne Brun; Lars Gustafson
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

2.  Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.

Authors:  G Lennox; J Lowe; M Landon; E J Byrne; R J Mayer; R B Godwin-Austen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-11       Impact factor: 10.154

Review 3.  Diffuse Lewy body disease in Japan.

Authors:  K Kosaka
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

4.  Cortical Lewy body dementia: clinical features and classification.

Authors:  W R Gibb; P J Luthert; I Janota; P L Lantos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

Review 5.  Diagnostic confirmation, severity, and subtypes of Alzheimer's disease. A short review on clinico-pathological correlations.

Authors:  H Förstl; P Fischer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

6.  Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.

Authors:  M B Schapiro; P Pietrini; C L Grady; M J Ball; C DeCarli; A Kumar; J A Kaye; J V Haxby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

7.  Dementia lacking distinctive histopathology: clinicopathological evaluation of 32 cases.

Authors:  P Giannakopoulos; P R Hof; C Bouras
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 8.  The role of clinical neuropsychology in the neurological diagnosis of Alzheimer's disease.

Authors:  H Spinnler; S Della Sala
Journal:  J Neurol       Date:  1988-05       Impact factor: 4.849

9.  Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans.

Authors:  D W Dickson; P Davies; C Bevona; K H Van Hoeven; S M Factor; E Grober; M K Aronson; H A Crystal
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Frontal lobe dementia and motor neuron disease.

Authors:  D Neary; J S Snowden; D M Mann; B Northen; P J Goulding; N Macdermott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.